HealthcareFew children affected by monkeypox so far, but risks...

Few children affected by monkeypox so far, but risks are higher in children 8 or younger


monkeypox
Credit: Pixabay/CC0 Public Domain

Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.

Young children would be a key target group for smallpox vaccination and other urgent measures if the outbreak widens, according to the review by Petra Zimmermann, MD, Ph.D., of University of Fribourg, Switzerland, and Nigel Curtis, Ph.D., of The University of Melbourne and Murdoch Children’s Research Institute, Australia. They provide an expert perspective on “What pediatricians need to know” about in children.

Past outbreaks raise concerns about monkeypox risks in young children

As of August 2022, nearly 47,000 laboratory-confirmed cases of monkeypox were reported worldwide. Of these, just 211 were in children and adolescents under 18 years. In the current outbreak, monkeypox virus appears to have spread largely by sexual or other close contact. The role of other routes of transmission, including via droplets and contaminated surfaces and objects, remains to be determined.

The outbreak reflects low population immunity due to low rates of vaccination against smallpox; smallpox and monkeypox viruses are both orthopoxviruses. Most cases of monkeypox are “self-limiting,” with a rash that progresses and resolves within 2 to 4 weeks. However, symptoms may be mild or absent, resulting in missed diagnoses and the potential for further spread.

Despite the low reported rates in children so far, there are special concerns about complications and other serious outcomes of monkeypox in children. “Children are reported to have an increased hospitalization rate and increased mortality, even in high-income countries,” Drs. Zimmermann and Curtis write. Based mainly on data from low-income countries, children under 8 are particularly at higher risk of complications, including potentially serious bacterial infections. Young children may also be at increased risk of complications related to scratching and spreading the infection to other parts of the body, including the eyes.

Most patients with monkeypox will recover with supportive care. However, more specific treatment is necessary for severe cases and high-risk groups—especially children under 8 years and those with underlying skin conditions. Other vulnerable groups include , immunocompromised patients, and people with eczema or with monkeypox rash near the mouth, eyes, and genitals.

In these high-risk cases, include antiviral medications such as tecovirimat, which is active against orthopoxviruses; and vaccinia immune globulin (VIG), used to treat complications of smallpox vaccination. However, “None of these treatments have been proven to be effective against monkeypox virus in humans in , and they are currently only recommended after consultation with national health authorities,” the reviewers write.

Smallpox vaccination is effective in preventing monkeypox, although the duration of protection is unknown. Because routine was discontinued after smallpox was eradicated—1972 in the United States—many people have never been vaccinated. One new type of vaccine (MVA-BN) has been approved by FDA for prevention of monkeypox, but it has not been “licensed or rigorously evaluated” in children.

For children who have been exposed to , medications or vaccines to prevent monkeypox have been recommended, again with “very limited data.” The reviewers also discuss some special considerations in pregnant/breastfeeding women and newborns born to infected women.

Especially since monkeypox can be asymptomatic, the outbreak could become uncontrolled and spread to , including . In that case, “additional urgent steps” would be needed—with playing a critical role. “Smallpox vaccination offers protection from monkeypox,” Drs. Zimmermann and Curtis conclude. “Should the current outbreak spread to , authorities should be prepared to rapidly implement vaccination of this age group.”


EU approves smallpox vaccine for use against monkeypox


More information:
Monkeypox—What Pediatricians Need to Know, DOI: 10.1097/INF.0000000000003720 , journals.lww.com/pidj/Fulltext … eed_to_Know.229.aspx

Citation:
Few children affected by monkeypox so far, but risks are higher in children 8 or younger (2022, October 28)
retrieved 30 October 2022
from https://medicalxpress.com/news/2022-10-children-affected-monkeypox-higher-younger.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Original Source Link

Latest News

RTO mandates won’t solve your employee engagement problems

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms...

Crypto community mulls ‘social layer’ solution to memecoin problem

Crypto trader Jordan Fish said a social layer might not work as there’s no way to “effectively socially...

Trump’s risible ‘reciprocal’ tariffs

This article is an on-site version of our Trade Secrets newsletter. Premium subscribers can sign up here to...

Sources: Tesla is bracing for a delay in Chinese approval for FSD, despite an earlier sign it would come in Q2; China is weighing...

Financial Times: Sources: Tesla is bracing for a delay in Chinese approval for FSD, despite an earlier sign...

Jamie Raskin Gives The Best Description Of Trump Corruption You’ll Hear

The Daily is independent, unwavering, ad-free, and solely supported by readers. Please consider supporting us by becoming a...

The mood is ‘uncertain, anxious’ at 2025’s first big U.S. science meeting

BOSTON — The official theme of the meeting of the American Association for the Advancement of Science, held...

Must Read

Abuses lurk deep in fashion supply chain

This article is an on-site version of our...

The mood is ‘uncertain, anxious’ at 2025’s first big U.S. science meeting

BOSTON — The official theme of the meeting...
- Advertisement -

You might also likeRELATED
Recommended to you